PACS President & COO Joshua Jergensen Sells $1.8M of Stock

Joshua Jergensen, President and Chief Operating Officer of PACS Group, Inc. PACS, sold 40,000 shares of stock on October 14, 2026. According to a Form 4 filed with the Securities and Exchange Commission, the shares were sold at a price of $44.50 each, bringing the total transaction value to roughly $1.8 million. The SEC filing notes that this transaction was carried out under a pre-arranged trading plan.

Inside Joshua Jergensen's PACS Trade

The planned sale reduced Jergensen's direct holdings in the healthcare facility operator. The trade took place on a day when PACS Group shares closed at $44.98. Insider sales of this nature are common among executives managing personal wealth or executing pre-scheduled equity plans and do not inherently signal a shift in company outlook.

Other Institutional Activity in PACS Group

Institutional investors made notable adjustments to their portfolios during recent reporting periods. Cohen & Steers Inc. reduced its holdings by 780,054 shares, ending the period with 8,343,381 shares valued at about $391.4 million. Crewe Advisors LLC grew its holdings by 553,034 shares to finish with 3,307,188 shares worth roughly $155.1 million. American Century Companies Inc added 1,298,580 shares to hold 3,108,196 shares valued near $145.8 million. Ameriprise Financial, Inc. grew its holdings by 873,697 shares, ending with 1,995,116 shares worth about $93.6 million. Meanwhile, Alyeska Investment Group, L.p. cut its position by 1,463,403 shares, leaving it with 1,539,065 shares valued at about $72.2 million.

PACS Group, Inc. Stock Down 2.1%

Shares recently traded around $46.76, sitting above their 50-day moving average of $43.66 and well ahead of the 200-day moving average of $39.31. The stock remains roughly 5.5% below its 52-week high of $49.49 while trading far above its 52-week low of $10.31. Wall Street analysts maintain a consensus strong buy rating on the shares with a mean price target of $59.00.

Recent Earnings

The company operates with a trailing twelve-month revenue total of $5.55 billion and earnings of $1.71 per share. Profitability metrics show a net margin of 4.8% alongside a return on equity of 27.9%. The next quarterly financial report is scheduled for release on November 9, 2026.

Dividend

PACS Group currently does not pay a dividend, maintaining a payout ratio of 0.0% as it reinvests capital into expanding its healthcare facility portfolio.

Insider Buying and Selling at PACS Group, Inc.

Insider transactions at the firm have included multiple sales in recent months. Mark Hancock sold shares valued at over $13 million on September 15, 2026. CEO Jason Hulse Murray also executed multiple sales, including 83,308 shares on October 5 and 36,692 shares on October 7, followed by additional transactions later in the month.

Analysts Set New Price Targets

Analyst firms covering the stock have adjusted their views through late summer and early autumn. UBS maintained a Buy rating on August 6 with a $60 price target. RBC Capital maintained an Outperform rating on the same day, lifting its target to $57. Truist Securities kept a Buy rating with a $62 target, while Oppenheimer maintained an Outperform rating with a $57 target. JP Morgan maintained an Overweight rating on September 4 with a $58 target.

About PACS Group

Headquartered in Salt Lake City, Utah, PACS Group operates skilled nursing facilities, assisted living centers, and senior care locations across the United States. The company focuses on acquiring, owning, and leasing healthcare-related properties to support aging populations.

Bottom Line

Executive trades like this one are typically scheduled well in advance through specific trading plans. Observers will look toward the company's earnings release on November 9, 2026, for updated financial details.